Gamma Investing LLC Mirum Pharmaceuticals, Inc. Transaction History
Gamma Investing LLC
- $1.01 Trillion
- Q3 2024
A detailed history of Gamma Investing LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 59 shares of MIRM stock, worth $2,625. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59
Previous 10
490.0%
Holding current value
$2,625
Previous $342,000
572.81%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MIRM
# of Institutions
190Shares Held
54MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$292 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$199 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$153 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$144 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$137 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.64B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...